Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Obstructive sleep apnea
Economic impact of diagnostic testing
9 evidence topics · 9 sources
Medicare diagnostic testing requirement for CPAP coverage
Sleep test documentation required for prior authorization of tirzepatide for obstructive sleep apnea
Share of U.S. diagnosis and treatment spending attributed to testing and office visits, 2015
Home versus laboratory diagnostic pathway: payer and provider costs in the HomePAP trial
“From the payer perspective, per subject costs for the laboratory-based pathway were $1,840 (95% confidence interval [CI] $1,660, $2,015) compared to $1,575 (95% CI $1,439, $1,716) for the home-based pathway under the base case. Costs were $264 (95% CI $39, $496, P = 0.02) in favor of the home arm.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“For payers, a home-based diagnostic pathway for obstructive sleep apnea with robust patient support incurs fewer costs than a laboratory-based pathway. For providers, costs are comparable if not higher, resulting in a negative operating margin.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Home versus laboratory diagnostic pathway: clinical outcomes in the HomePAP trial
Home versus laboratory diagnostic pathway: functional outcome in veterans
“Functional outcome and treatment adherence in patients evaluated according to a home testing algorithm is not clinically inferior to that in patients receiving standard in-laboratory polysomnography.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Cost-effectiveness of diagnostic strategies with CPAP in a U.S. lifetime model
“Over the lifetime horizon in a population with 50% prevalence of OSA, full-night polysomnography in conjunction with CPAP therapy is the most economically efficient strategy at any willingness-to-pay greater than $17,131 per-QALY gained because it dominates all other strategies in comparative analysis.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Cost-utility of polysomnography, home testing, and empirical CPAP
Systematic review of economic evaluations of diagnostic strategies
“Twenty-nine studies were included. Fifteen studies included an economic evaluation alongside a clinical trial and 14 studies were model-based economic analyses.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Substantial methodological heterogeneity was identified across studies, including variation in diagnostic thresholds and scoring criteria used, model structures and assumptions regarding treatment adherence.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote